Earnings & Investor News · Week of Oct 26, 2026
Community banks lift Q3 profits: the week in earnings
Community banks posted higher third-quarter 2026 earnings, while High Liner Foods agreed to a cash sale to Umios and Acumen set a trial readout date.
Bank holding companies dominated the week's releases. Ponce Financial Group, Citizens Community Bancorp and Bank of Marin Bancorp each reported third-quarter 2026 net income above both the prior quarter and the year-earlier period, and First Resource Bancorp described its quarter as a record. Citizens Community and Bank of Marin both pointed to wider net interest margins, citing new loan originations, loan repricing, higher loan yields and lower deposit costs.
Outside banking, High Liner Foods agreed to be acquired by Umios for C$27.00 per share in cash. Acumen Pharmaceuticals said it expects topline Phase 2 results for sabirnetug in November 2026. Scienjoy released delayed second-quarter and first-half 2026 results, and FF EAI Robotics Ecosystem scheduled a listing ceremony and investor day.
Ponce Financial Group, Inc.
Ponce Financial Group, Inc. Reports Third Quarter 2026 Results
Ponce Financial Group reported third-quarter 2026 net income available to common stockholders of $18.0 million, or $0.76 per diluted share, up from $8.2 million, or $0.35, in the second quarter and $6.2 million, or $0.27, a year earlier. The company says the quarter included a $5.9 million benefit for income taxes, against $57.5 million in total interest and dividend income and $23.5 million in interest expense.
Citizens Community Bancorp Inc.
Citizens Community Bancorp, Inc. Reports Third Quarter 2026 Earnings of $0.56 Per Share;
Citizens Community Bancorp reported third-quarter 2026 earnings of $5.4 million, or $0.56 per diluted share, compared with $1.1 million, or $0.11, in the second quarter and $3.7 million, or $0.37, a year earlier. The company attributes the quarter-over-quarter change to a 15 basis point higher net interest margin and a $4.2 million decrease in the provision for credit losses.
Bank of Marin Bancorp
Bank of Marin Bancorp
Bank of Marin Bancorp reported third-quarter 2026 net income of $9.9 million, or $0.62 per diluted share, up from $9.2 million in the prior quarter and $7.5 million a year earlier. The company says net interest margin expansion from higher loan yields and reduced deposit costs drove the increase, and that loan growth came from organic originations and a loan pool purchase.
Scienjoy Holding Corporation
Scienjoy Holding Corporation Reports Second Quarter and First Half 2026 Unaudited Financial Results
Scienjoy Holding Corporation announced unaudited financial results for the second quarter and first half of 2026. The company describes itself as an AI technology company combining digital entertainment and enterprise AI solutions; the release excerpt did not include figures.
High Liner Foods Incorporated
High Liner Foods Enters into Agreement to Be Acquired by Umios for C$27.00 per Share in Cash
High Liner Foods has agreed to be acquired by Umios for C$27.00 per share in cash, an offer the company describes as fully financed. High Liner says the combination pairs Umios' global sourcing capabilities with its own processing expertise and brands to form a North American growth platform.
FF EAI Robotics Ecosystem Inc.
FFR to Hold Listing Ceremony and Investor Day on October 26; FFAI Announces Rescheduling of YT Jia's Investor Weekly Report to October 26
FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) scheduled its Listing Ceremony and Investor Day for October 26, where management was to outline the company's plans. Faraday Future also moved founder and Global CEO YT Jia's Investor Weekly Report to the same date.
First Resource Bank
First Resource Bancorp, Inc. Reports Record Third Quarter 2026 Financial Results
First Resource Bancorp reported what it calls record financial results for the third quarter ended September 30, 2026. President and CEO Lauren C. Ranalli said the bank has grown its balance sheet and profitability at the same time; the release excerpt did not include figures.
Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results
Acumen Pharmaceuticals reported third-quarter 2026 results and said it expects topline results in November 2026 from its ALTITUDE-AD Phase 2 study of sabirnetug in early Alzheimer's disease. The company also says it is continuing IND-enabling work on its Enhanced Brain Delivery program, which pairs blood-brain barrier-penetrating technology with an AβO-selective antibody.
This roundup is written with AI assistance from the press releases listed above, using only what they state. The releases are the companies' own announcements, not Times Beats reporting.